Busquets C, Coll M J, Merinero B, Ugarte M, Ruiz M A, Martinez Bermejo A, Ribes A
Institut de Bioquímica Clínica, Barcelona, Spain.
Prenat Diagn. 2000 Sep;20(9):761-4.
Various biochemical strategies are followed for the prenatal diagnosis of glutaric aciduria type I (GA I). However, since the description of patients with normal excretion of glutarate and significant residual activity, the difficulties of prenatal biochemical diagnosis are obvious. The characterization of the glutaryl-CoA dehydrogenase (GCDH) gene has allowed us to develop a single strand conformation polymorphism (SSCP) screening method, followed by direct sequencing, to identify the disease causing mutations in patients with GA I. Here we report the first prenatal diagnoses based on DNA analysis in chorionic villi biopsy or cultured amniotic fluid cells in three families at risk for GA I. Our results show that this strategy provides a fast and reliable method for prenatal diagnosis. In addition we report two new mutations (1209-1210ins G and R161W) in the GCDH gene that occurred at hypermutable loci.
对于I型戊二酸血症(GA I)的产前诊断,人们采用了多种生化策略。然而,自从有了戊二酸排泄正常但仍有显著残余活性的患者的描述后,产前生化诊断的困难就很明显了。戊二酰辅酶A脱氢酶(GCDH)基因的特征使我们能够开发一种单链构象多态性(SSCP)筛查方法,随后进行直接测序,以鉴定GA I患者中导致疾病的突变。在此,我们报告了首例基于对三个有GA I风险家庭的绒毛取样活检或羊水细胞培养进行DNA分析的产前诊断。我们的结果表明,这一策略为产前诊断提供了一种快速且可靠的方法。此外,我们报告了GCDH基因中发生在高变位点的两个新突变(1209 - 1210ins G和R161W)。